Discusses new treatment strategies for malignant mesothelioma, pulmonary edema, fibrosis, asthma, emphysema, and bronchiectasis. Proteoglycans in Lung Disease considers glycosaminoglycans as novel therapeutic agents or targets in lung disease the role of proteoglycans in determining mechanical behavior of lung tissue
